A risk analysis framework for the long-term management of antibiotic resistance in food-producing animals

International Journal of Antimicrobial Agents

Volumn 20, Issue 3, 2002, Pages 153-164

  Salisbury, Janet G ^a   Nicholls, Terence J ^b   Lammerding, Anna M ^c   Turnidge, John ^d   Nunn, Michael J ^b  

^a Biotext   (Australia)

^b Forestry and Fisheries Australia   (Australia)

^c CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^d North Adelaide SA   (United States)

Author keywords

Antibiotic resistance; Food producing animal; Risk analysis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; DECISION MAKING; FOOD CHAIN; FOOD INDUSTRY; HUMAN; INFECTION RISK; LIVESTOCK; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT FAILURE; ZOONOSIS;

EID: 0036711376     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00169-3     Document Type: Article

References (45)

1. World Health Organization (WHO). The medical impact of the use of antimicrobials in food animals. Report of WHO meeting, Berlin, Germany, 13-17 October 1997. Volumes 1 and 2: Report and background papers.
2. Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR) . The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. 1999;52 Commonwealth Department of Health and Aged Care and Commonwealth Department of Agriculture, Fisheries and Forestry, Canberra, Australia.
3. Barton M.D. Does the use of antibiotics in animals affect human health. Aust. Vet. J. 76:1998;177-180.
4. Lammerding A.M. An overview of microbial food safety risk assessment. J. Food Prot. 60:1998;1420-1425.
5. Gorbach S.L. Antimicrobial use in animal feed-time to stop. New Engl. J. Med. 345:2001;1202-1203.
6. Nunn M. Quarantine risk analysis. Aust. J. Agric. Res. Econ. 41:1997;559-578.
7. Food and Agriculture Organization of the United Nations (FAO) and World Health Organization (WHO). Application of risk analysis to food standards issues. Report of the Joint FAO/WHO Expert Consultation, Geneva, March 1995.
8. Sim M.R., McNeil J.J. Risky business: health risk assessment and public health policy on environmental carcinogens. Med. J. Aust. 170:1999;372-374.
9. Nairn M.E., Allen P.G., Inglis A.R., Tanner C. Australian quarantine: a shared responsibility. 1996;83-84 Department of Primary Industries and Energy, Canberra, Australia.
10. Collignon P. Antibiotic resistance: is it leading to the re-emergence of many infections from the past, Recent Adv Microbiol 1997;203-56.
11. World Health Organization (WHO). The use of antibiotic growth promoters: perspective of producers from a developing country. Obviar LA, editor. Report of a WHO meeting, Geneva, Switzerland, 13-17 June 2000.
12. Joint Expert Technical Advisory Committee on Antibiotic Resistance . The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. 1999;7-16 Commonwealth Department of Heath and Aged Care and Commonwealth Department of Agriculture, Fisheries and Forestry, Australia, Canberra, Australia.
13. Mitsuhashi S. Drug resistance in bacteria: history, genetics and biochemistry. J. Int. Med. Res. 21:1993;1-14.
14. Collier L., Barlows A., Sussman M., Topley and Wilson's microbiology and microbial infections. 9th ed. 1998;Arnold Press, Sydney, Australia.
15. Joint Expert Technical Advisory Committee on Antibiotic Resistance . The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. 1999;11-13 Commonwealth Department of Heath and Aged Care and Commonwealth Department of Agriculture, Fisheries and Forestry, Canberra.
16. Baquero F., Negri J. Antibiotic-selective environments. Clin. Infect. Dis. 27:(Suppl.):1998;S5-S11.
17. UK House of Lords. Select Committee on Science and Technology - seventh report (Session 1997-1998)
18. Crerar S.J., Nicholls T.J., Barton M.D. Multi-resistant Salmonella typhimurium DT104 - implications for animal industries and the veterinary profession. Aust. Vet. J. 77:1999;170-171.
19. Smith K.E., Besser J.M., Hedberg C.W., et al. Quinilone-resistant Campylobacter jejuni infections in Minnesota 1992-1998 investigation team. New Engl. J. Med. 340:1999;1525-1532.
20. Aarestrup F.M., Nielsen E.M., Madsen M., Engberg J. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle and broilers in Denmark. Antimicrob. Agents Chemother. 41:1997;2244-2250.
21. French G.L. Enterococci and vancomycin resistance. Clin. Infect. Dis. 27:(Suppl.):1998;S75-S83.
22. Manges A.R., Johnson J.R., Foxman B., O'Bryan T.T., Fullerton K.E., Riley L.W. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. New Engl. J. Med. 345:2001;1007-1013.
23. Fey P.D., Safranek T.J., Rupp M.E., et al. Cetriaxone-resistant salmonella infection acquired by a child from cattle. New Engl. J. Med. 342:2001;1242-1249.
24. Huycke M.M., Sahm D.F., Gilmore M.S. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4:1998;239-249.
25. Woodforde N. Glycopeptide-resistant enterococci: a decade of experience. J. Med. Microbiol. 47:1998;849-862.
26. Chee-Sanford J.C., Aminov R.I., Krapac I.J., Garrigues-Jeanjean N., Mackie R.I. Occurrence and diversity of tetracycline-resistant genes in lagoons and groundwater underlying two swine production facilities. Appl. Environ. Microbiol. 67:2001;1494-1502.
27. Jensen LB. Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs and poultry. Antimicrob Agents Chemother 1998;42:2463-2464
28. Joint Expert Technical Advisory Committee on Antibiotic Resistance . The use of antibiotics in food producing animals: antibiotic-resistant bacteria in animals and humans. 1999;41-60 Commonwealth Department of Heath and Aged Care and Commonwealth Department of Agriculture, Fisheries and Forestry, Canberra, Australia. Chapter 5.
29. Noble W.C., Virani Z., Cree R.G. Co-transfer of vancomycin resistance and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72:1992;195-198.
30. Threlfall E.J. Epidemic Salmonella typhimurium DT 104 - a truly international multiresistant clone. J. Antimicrob. Chemother. 46:2000;7-10.
31. Klugman K.P. Epidemiology, control and treatment of multiresistant pneumococci. Drugs. 53:(Suppl. 2):1996;42-46.
32. Hogue A, Akkina J, Angula F, et al. Situation assessment - Salmonella typhimurium DT104. Washington, DC: Food Safety Inspection Service, United States Department of Agriculture, December 1977 http://www.fsis.usda.gov/OPHS/stdt104.htm (cited January 2002).
33. Hrudey S.E. Quantitative cancer risk assessment - pitfalls and progress. Hester R.E., Harrison R.M., Issues in environmental science and technology, no. 9. 1998;The Royal Society of Chemistry, London.
34. Australia New Zealand Food Authority (ANZFA) . Framework for the assessment and management of food-related health risks. 1996;ANZFA, Canberra, Australia.
35. Office International des Epizooties (OIE). International Animal Health Code, 10th edition. Paris: OIE, 2001, http://www.oie.int/eng/normes/mcode/a_summry.htm (cited January 2002).
36. National Academy of Sciences and National Research Council (NAS-NRC) . Risk assessment in the federal government: managing the process. 1983;NAS-NRC Committee on the Institutional Means for the Assessment of Risks to Public Health, National Academy Press, Washington, DC.
37. Covello V.T., Merkhofer M.W. Risk assessment methods: approaches for assessing health and environmental risks. 1993;Plenum Press, New York and London.
38. OIE world wide consultation on antimicrobial resistance. http://www.anmv.afssa.fr/oiecc/abr (cited January 2002).
39. Council for Agricultural Science and Technology (CAST). Foodborne pathogens: review of recommendations. Ames, IA, USA: CAST, 1998. http://www.cast-science.org/pat2/pat2.htm (cited January 2002).
40. Strauss H.S. Lessons from chemical risk assessment. Levin M.A., Straus H.S., Risk assessment in genetic engineering. 1991;McGraw-Hill, New York.
41. Bezoen A, van Harem W, Hanekamp JC. Emergence of a debate: AGPs and Public Health. Amsterdam: Heidelberg Appeal Nederland Foundation, 1999.
42. Strauss H.S., Levin M.A. Use of fate and transport (dispersal) models in microbial risk assessment. Levin M.A., Strauss H.S., Risk assessment in genetic engineering. 1991;McGraw-Hill, New York.
43. Food and Drug Administration, Center for Veterinay Medicine (FDA-CVM) Risk assessment on the human health impact of fluoroquinolone resistant campylobacter associated with the consumption of chicken, FDA-CVM, October 2000. http://www.fda.gov/cvm/antimicrobial/Risk_asses.htm (cited January 2002).
44. Joint Expert Technical Advisory Committee on Antibiotic Resistance . The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. 1999;143-169 Commonwealth Department of Heath and Aged Care and Commonwealth Department of Agriculture, Fisheries and Forestry, Canberra, Australia.
45. Nicholls T.J. Changing patent laws could be a health move to combat resistance. Nature. 409:2000;558. letter.